117 related articles for article (PubMed ID: 35526853)
1. Preparative Production and Purification of Recombinant Human Cyclophilin A.
Kalinina AA; Kolesnikov AV; Kozyr AV; Kulikova NL; Zamkova MA; Kazansky DB; Khromykh LM
Biochemistry (Mosc); 2022 Mar; 87(3):259-268. PubMed ID: 35526853
[TBL] [Abstract][Full Text] [Related]
2. Evidences of monomer, dimer and trimer of recombinant human cyclophilin A.
Zhang XC; Wang WD; Wang JS; Pan JC; Zou GL
Protein Pept Lett; 2011 Dec; 18(12):1188-93. PubMed ID: 21728990
[TBL] [Abstract][Full Text] [Related]
3. [Expression, purification and characterization of recombinant human cyclophilin A].
Li F; Zhao Q; Wu J; Shan X
Wei Sheng Wu Xue Bao; 1998 Jun; 38(3):193-6. PubMed ID: 12549331
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic Parameters of Recombinant Human Cyclophilin A in Mice.
Kalinina A; Grigorieva E; Smirnova A; Kazansky D; Khromykh L
Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):57-69. PubMed ID: 38040985
[TBL] [Abstract][Full Text] [Related]
5. Cyclophilin A is a factor of antitumor defense in the early stages of tumor development.
Kalinina A; Golubeva I; Kudryavtsev I; Khromova N; Antoshina E; Trukhanova L; Gorkova T; Kazansky D; Khromykh L
Int Immunopharmacol; 2021 May; 94():107470. PubMed ID: 33640856
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and refolding in vitro of a recombinant human cyclophilin A mutant: effect of a single Pro/Ser substitution on cyclophilin A structure and properties.
Xu LR; Yan X; Luo M; Guan YX; Yao SJ
Biotechnol Prog; 2008; 24(2):302-10. PubMed ID: 18333624
[TBL] [Abstract][Full Text] [Related]
7. Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway.
Obchoei S; Sawanyawisuth K; Wongkham C; Kasinrerk W; Yao Q; Chen C; Wongkham S
Tumour Biol; 2015 Feb; 36(2):849-59. PubMed ID: 25296734
[TBL] [Abstract][Full Text] [Related]
8. PPIase independent chaperone-like function of recombinant human Cyclophilin A during arginine kinase refolding.
Zhang XC; Wang WD; Wang JS; Pan JC
FEBS Lett; 2013 Mar; 587(6):666-72. PubMed ID: 23376614
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli.
Boismenu R; Semeniuk D; Murgita RA
Protein Expr Purif; 1997 Jun; 10(1):10-26. PubMed ID: 9179285
[TBL] [Abstract][Full Text] [Related]
10. The Role of Recombinant Human Cyclophilin A in the Antitumor Immune Response.
Kalinina AA; Silaeva YY; Kazansky DB; Khromykh LM
Acta Naturae; 2019; 11(2):63-67. PubMed ID: 31413881
[TBL] [Abstract][Full Text] [Related]
11. [Expression of recombinant human BMP-6 in Escherichia coli and its purification and bioassay in vitro].
Yang JH; Zhao L; Yang S; Wu SQ; Zhang J; Zhu TH
Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):556-60. PubMed ID: 15969083
[TBL] [Abstract][Full Text] [Related]
12. Expression and purification of recombinant human annexin V in Escherichia coli.
Zhang LN; Yang X; Hua ZC
Prep Biochem Biotechnol; 2000 Nov; 30(4):305-12. PubMed ID: 11065275
[TBL] [Abstract][Full Text] [Related]
13. Analyses of the toxic properties of recombinant human Cyclophilin A in mice.
Kalinina A; Zamkova M; Antoshina E; Trukhanova L; Gorkova T; Kazansky D; Khromykh L
J Immunotoxicol; 2019 Dec; 16(1):182-190. PubMed ID: 31646917
[TBL] [Abstract][Full Text] [Related]
14. [Overexpression and purification of Escherichia coli holo-acyl carrier protein and synthesis of acyl carrier protein].
Wang L; Yang J; Huang C; Wang H
Wei Sheng Wu Xue Bao; 2008 Jul; 48(7):963-9. PubMed ID: 18837378
[TBL] [Abstract][Full Text] [Related]
15. Expression of Recombinant pET22b-LysK-Cysteine/Histidine-Dependent Amidohydrolase/Peptidase Bacteriophage Therapeutic Protein in Escherichia coli BL21 (DE3).
Kashani HH; Moniri R
Osong Public Health Res Perspect; 2015 Aug; 6(4):256-60. PubMed ID: 26473093
[TBL] [Abstract][Full Text] [Related]
16. High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials.
Frankel AE; Ramage J; Latimer A; Feely T; Delatte S; Hall P; Tagge E; Kreitman R; Willingham M
Protein Expr Purif; 1999 Jun; 16(1):190-201. PubMed ID: 10336877
[TBL] [Abstract][Full Text] [Related]
17. [Expression, purification and immunoreactivity characterization of extracellular antigenic domains of NMDAR1 protein].
Bao D; Li W; Shi L; Li Q
Sheng Wu Gong Cheng Xue Bao; 2017 Dec; 33(12):1979-1988. PubMed ID: 29271175
[TBL] [Abstract][Full Text] [Related]
18. Recombinant expression, purification and characterization of acetylated LysargiNase from Escherichia coli with high activity and stability.
Zhang J; Zhao M; Xiao W; Chang L; Wang F; Xu P
Rapid Commun Mass Spectrom; 2019 Jun; 33(12):1067-1075. PubMed ID: 30900783
[TBL] [Abstract][Full Text] [Related]
19. Cyclophilin A differentially activates monocytes and endothelial cells: role of purity, activity, and endotoxin contamination in commercial preparations.
Payeli SK; Schiene-Fischer C; Steffel J; Camici GG; Rozenberg I; Lüscher TF; Tanner FC
Atherosclerosis; 2008 Apr; 197(2):564-71. PubMed ID: 17919644
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of cyclophilin A-like protein from Piriformospora indica for its potential role to abiotic stress tolerance in E. coli.
Trivedi DK; Ansari MW; Dutta T; Singh P; Tuteja N
BMC Res Notes; 2013 Dec; 6():555. PubMed ID: 24365575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
